Neuroleptics election and clinical outcomes in acute psychosis: A comparative study of risperidone versus other neuroleptics;Elección de neuroléptico y respuesta clínica en psicosis aguda: Un estudio comparativo de risperidona frente a otros neurolépticos

Anales de Psiquiatria

Volumn 20, Issue 4, 2004, Pages 167-171

  Pedrós Roselló, Alfonso ^a   Tenias J M ^a  

^a HOSPITAL LLUÍS ALCANYÍS   (Spain)

Author keywords

Acute psychosis; Antipsichotic agents; Cohort studies; Risperidone

Indexed keywords

ANTIPARKINSON AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; RISPERIDONE;

ACUTE PSYCHOSIS; ADULT; AGGRESSION; AGITATION; ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; SCHIZOPHRENIFORM DISORDER; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 3042595154     PISSN: 02130599     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Pichot P. The concept of "bouffée délirante" with special reference to the Scandinavian concept of reactive psychosis. Psychopathology 1986; 19: 35-43.
2. Retterstol N. Present state of reactive psychosis in Scandinavia. Psychopathology 1987; 20: 68-71.
3. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151: 825-35.
4. Peukens J. Risperiodne in the treatment of chronic schizophrenic patients: a multinational, multicentre double-blind, parallel-group study versus haloperidol. Br J Psychiatry 1995; 166: 712-26.
5. Kopola LC, Good KP, Honer WG. Extrapiramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. J Clin Psychopharmacol 1997; 17: 308-13.
6. Emsley RA. Risperidoen in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group. Schizophr Bull 1999; 25: 721-9.
7. Janicak PG, Keck PE Jr, Davis JM, Kasckow JW, Tugrul K, Dowd SM, et al. A double-blind randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder. J Clin Psychopharmacol 2001; 21: 360-8.
8. Daradkeh TK, Reda F, Karim L. Efficacy and safety of risperidone in psychotic patients: an open study. J Int Med Res 1996; 24: 291-5.
9. Yap HL, Mahendran R, Lim D, Liow PH, Lee A, Phang S, Tiong A. Risperidone in the treatment of first episode psychosis. Singapore Med J 2001; 42: 170-3.
10. Merlo MC, Hofer H, Gekle W, Berger G, Ventura J, Panhuber I, et al. Risperidone, 2 mg/day vs 4 mg/day, in first-episode, acutely pschotic patients: treatment efficacy and effects on fine motor functioning. J Clin Psychiatry 2002; 63: 885-91.